Patents by Inventor Dino De Cicco
Dino De Cicco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140046360Abstract: An implantable device for containing emboli within an atrial appendage may include an expandable frame having a plurality of supports projecting distally from a proximal hub, a mesh barrier provided on proximal sections of the supports, and a plurality of tissue anchors provided on the supports for engaging tissue when the device is positioned in an atrial appendage.Type: ApplicationFiled: September 3, 2013Publication date: February 13, 2014Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
-
Publication number: 20130331884Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes a pumpable injectable material and a retention member having a tissue penetrating shaft which extends from a proximal end of the device to a distal end of the device.Type: ApplicationFiled: August 14, 2013Publication date: December 12, 2013Inventors: Erik J. Van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
-
Patent number: 8535343Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes a pumpable injectable material and a retention member having a tissue penetrating shaft which extends from a proximal end of the device to a distal end of the device.Type: GrantFiled: May 17, 2011Date of Patent: September 17, 2013Assignee: Atritech, Inc.Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
-
Patent number: 8535290Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: GrantFiled: July 13, 2012Date of Patent: September 17, 2013Assignee: Covidien LPInventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
-
Patent number: 8523897Abstract: An implantable device for containing emboli within an atrial appendage may include an expandable frame having a plurality of supports projecting distally from a proximal hub, a mesh barrier provided on proximal sections of the supports, and a plurality of tissue anchors provided on the supports for engaging tissue when the device is positioned in an atrial appendage.Type: GrantFiled: September 27, 2006Date of Patent: September 3, 2013Assignee: Atritech, Inc.Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
-
Publication number: 20120283699Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: ApplicationFiled: July 13, 2012Publication date: November 8, 2012Applicant: TYCO HEALTHCARE GROUP LPInventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
-
Patent number: 8241241Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: GrantFiled: June 15, 2010Date of Patent: August 14, 2012Assignee: Tyco Healthcare Group LPInventors: Michael A. Evans, Denise Demarias, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
-
Patent number: 8080032Abstract: A device and method for obliterating or occluding a body cavity or passageway, in particular, the left atrial appendage of a patient's heart. The procedure can be carried out intraoperatively, but is preferably carried out percutaneously by use of a delivery catheter to position an occluding device adjacent a patient's left atrial appendage. The occluding device may prevent the passage of embolic or other material to or from the left atrial appendage by volumetrically filling the appendage, closing the opening of the appendage with an occluding member, or pulling the tissue around the opening of the appendage together and fixing it in a closed state.Type: GrantFiled: September 30, 2003Date of Patent: December 20, 2011Assignee: Atritech, Inc.Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
-
Publication number: 20110218566Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.Type: ApplicationFiled: May 17, 2011Publication date: September 8, 2011Applicant: ATRITECH, INC.Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
-
Publication number: 20110046542Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: ApplicationFiled: June 15, 2010Publication date: February 24, 2011Applicant: Bacchus Vascular Inc.Inventors: Michael A. Evans, Denise Demarias, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
-
Patent number: 7763010Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: GrantFiled: May 8, 2002Date of Patent: July 27, 2010Assignee: Bacchus Vascular inc.Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
-
Publication number: 20070083227Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.Type: ApplicationFiled: September 27, 2006Publication date: April 12, 2007Inventors: Erik van der Burg, Dino De Cicco, Andrew Frazier, Alex Khairkahan, Marc Kriedler, Michael Lesh, Chad Roue
-
Patent number: 7128073Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.Type: GrantFiled: November 8, 1999Date of Patent: October 31, 2006Assignee: ev3 Endovascular, Inc.Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
-
Patent number: 6994092Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and a plurality of tissue retention structures. The tissue retention structures inhibits movement of the device from the left atrial appendage. Methods are also disclosed.Type: GrantFiled: August 15, 2003Date of Patent: February 7, 2006Assignee: ev3 Sunnyvale, Inc.Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
-
Patent number: 6929633Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, agitate the clot and agent, and aspirate broken-up clot from the blood vessel. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.Type: GrantFiled: October 21, 2002Date of Patent: August 16, 2005Assignee: Bacchus Vascular, Inc.Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang, Jody Maria Cimbalo, Stephen Leeflang
-
Publication number: 20050004652Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.Type: ApplicationFiled: April 22, 2004Publication date: January 6, 2005Inventors: Eric van der Burg, Dino De Cicco, Andrew Frazier, Alex Khairkahan, Marc Kriedler, Michael Lesh, Chad Roue
-
Publication number: 20040230222Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.Type: ApplicationFiled: January 30, 2004Publication date: November 18, 2004Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
-
Publication number: 20040220610Abstract: A biocompatible laminate fabric includes a porous first membrane layer, a porous second membrane layer, and an open mesh bonding layer between the first and second membrane layers. The bonding layer holds the first and second membrane layers together by extending into one or more pores of each membrane layer.Type: ApplicationFiled: March 17, 2004Publication date: November 4, 2004Inventors: Marc S. Kreidler, Dino De Cicco, Eric J. van der Burg, Richard S. Kusleika
-
Publication number: 20040098031Abstract: A device and method for obliterating or occluding a body cavity or passageway, in particular, the left atrial appendage of a patient's heart. The procedure can be carried out intraoperatively, but is preferably carried out percutaneously by use of a delivery catheter to position an occluding device adjacent a patient's left atrial appendage. The occluding device may prevent the passage of embolic or other material to or from the left atrial appendage by volumetrically filling the appendage, closing the opening of the appendage with an occluding member, or pulling the tissue around the opening of the appendage together and fixing it in a closed state.Type: ApplicationFiled: September 30, 2003Publication date: May 20, 2004Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
-
Publication number: 20040034366Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and a plurality of tissue retention structures. The tissue retention structures inhibits movement of the device from the left atrial appendage. Methods are also disclosed.Type: ApplicationFiled: August 15, 2003Publication date: February 19, 2004Applicant: EV3 SUNNYVALE, INC., a California corporationInventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue